Non-User Fee Dollars Increased In US FDA’s Updated FY 2026 Budget Request

The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.

FDA Commissioner Martin Makary answers questions from a Senate Appropriations subcommittee. (Screenshot of Senate Broadcast)

More from Leadership

More from HBW Insight